{"id":"W4402554992","doi":"10.1093/ndt/gfae203","title":"Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial","year":2024,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; University of Toronto","funders":"Medical Research Council; Astellas Pharma; University of Oxford; British Heart Foundation; Novo Nordisk; National Institute for Health and Care Research; Regeneron Pharmaceuticals; Fresenius Medical Care North America; European Society of Cardiology; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Empagliflozin; Medicine; Gout; Uric acid; Internal medicine; Kidney disease; Renal function; Placebo; Diabetes mellitus; Hazard ratio; Endocrinology; Hyperuricemia; Creatinine; Urology; Gastroenterology; Type 2 diabetes; Confidence interval; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01195434,0.001716438,0.003725659,0.0003453246,0.0003173741,0.001572927,0.0008132496,0.001235445,0.004473669],"category_scores_gemma":[0.01404539,0.0005113235,0.007718168,0.000773456,0.0005259053,0.000831919,0.001092728,0.00197775,0.0004234706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005585904,"about_ca_system_score_gemma":0.0007778328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009527626,"about_ca_topic_score_gemma":0.001742183,"domain_scores_codex":[0.9936963,0.004847967,0.0003755098,0.000392923,0.0003471583,0.0003401033],"domain_scores_gemma":[0.9923165,0.004309217,0.001559578,0.0008515902,0.0004261496,0.0005370277],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8702102,0.0009344658,0.01925365,0.004658703,0.07774062,0.0001571533,0.0001359848,0.00226191,0.001078562,0.0004205712,0.003066264,0.02008197],"study_design_scores_gemma":[0.6286356,0.03849347,0.1561765,0.001307904,0.1614192,0.0003689031,0.0002025305,0.004567377,0.0007375371,0.002674086,0.005253922,0.0001628713],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9454336,0.03963518,0.002149988,0.001563672,0.0003636857,0.001642257,0.006125333,0.0001067077,0.002979589],"genre_scores_gemma":[0.9872492,0.003765356,0.001304703,0.0006809865,0.0003587443,0.001668231,0.004009665,0.00003449864,0.0009286879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01195434,"threshold_uncertainty_score":0.06322134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02752337371675091,"score_gpt":0.3067359504669705,"score_spread":0.2792125767502196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}